A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Emergency number back in use after nationwide technical fault
Weave Introduces Message Analytics Tool and New Enhancements to Phone Analytics Platform
Netflix Tell US Consumers to Stop Sharing Accounts
The Best NAS (Network Attached Storage) Devices for 2023
Ionic Mineral Technologies Names Eric Miller as CFO
Knightscope Announces Automated Gunshot Detection
Starship launch LIVE: Elon Musk’s SpaceX to launch world’s biggest rocket – and try to avoid another explosion
Poland Wants to Speed Up Coal Farewell Under New Government